Dengue Vaccine! Tetravalent Vaccine TAK-003 Enters Review in EU
Takeda Pharmaceutical recently announced that the European Drug Administration (EMA) has accepted the declaration of its dengue vaccine TAK-003, which is developed for people between the ages of 4 and 60 toRead More…